Cocrystal Pharma, Inc.

This early-stage study tested a new oral medication called CC-42344, designed to stop Influenza A virus from multiplying in the body. Researchers gave the drug to 80 healthy volunteers to check if it was safe and to measure how the body processes it. The study focused on finding …